NCT00343239 - Docetaxel in Locally Advanced Gastric Adenocarcinoma | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

March 31, 2012

Study Completion Date

March 31, 2012

Conditions

Stomach Neoplasms

Interventions

DRUG

Docetaxel

"Formulation: infusion solution~Route of administration: IV infusion on the first day of each 21-day cycle~Dose regimen: 75 mg/m2"

DRUG

Cisplatin

"Formulation: infusion solution~Route of administration: IV infusion on the first day of each 21-day cycle~Dose regimen: 75 mg/m2"

DRUG

Fluorouracil

"Formulation: infusion solution~Route of administration: IV infusion on the first day of each 21-day cycle~Dose regimen: 750 mg/m2/day for 5 days"

Trial Locations (1)

Sanofi-Aventis Administrative Office, Istanbul